SCHEMBL1397641

SCHEMBL1397641

NCCOCCOCCOCCOCCC=O

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9952291 1.00 HIF1A (0.32) HIF1A
SCHEMBL14873888 1.00 HIF1A (0.32) HIF1A
SCHEMBL725752 1.00 HIF1A (0.32) HIF1A
SCHEMBL20169646 1.00 HIF1A (0.32) HIF1A
SCHEMBL16329660 1.00 HIF1A (0.32) HIF1A
SCHEMBL15773944 1.00 HIF1A (0.32) HIF1A
SCHEMBL16329771 1.00 HIF1A (0.32) HIF1A
SCHEMBL16692019 0.97
SCHEMBL16329560 0.93
SCHEMBL23130636 0.86 HIF1A (0.41) HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118021978-A GHRH antagonists for use in methods of treating sarcoidosis 迈阿密大学 2024-05-14 CN claimed
EP-4331674-A2 GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS University of Miami (US) 2024-03-06 EP claimed
EP-3999095-B1 GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS UNIV MIAMI (US) 2023-09-13 EP claimed
EP-3999095-A1 GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS University of Miami (US) 2022-05-25 EP claimed
US-20220143149-A1 GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS 2022-05-12 US claimed
CN-114126653-A GHRH antagonists for use in methods of treating sarcoidosis 迈阿密大学 2022-03-01 CN claimed
WO-2021011874-A1 GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS UNIVERSITY OF MIAMI (US) 2021-01-21 WO claimed
US-20200276273-A1 METHOD FOR TREATING MYELOID LEUKEMIA THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS 2020-09-03 US claimed
WO-2019060601-A1 METHOD FOR TREATING MYELOID LEUKEMIA UNIVERSITY OF MIAMI (US) 2019-03-28 WO claimed
WO-2024151890-A1 LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME PROFOUNDBIO US CO. (US) 2024-07-18 WO disclosed
WO-2024127022-A1 HETEROCYCLIC COMPOUNDS TARGETING THE NUDT5 PROTEIN OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2024-06-20 WO disclosed
CN-118021978-A GHRH antagonists for use in methods of treating sarcoidosis 迈阿密大学 2024-05-14 CN disclosed
EP-4331674-A2 GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS University of Miami (US) 2024-03-06 EP disclosed
CN-114126653-B GHRH antagonists for use in methods of treating sarcoidosis 迈阿密大学 2024-02-20 CN disclosed
WO-2010048582-A1 BIOSYNTHETICALLY GENERATED PYRROLINE-CARBOXY-LYSINE AND SITE SPECIFIC PROTEIN MODIFICATIONS VIA CHEMICAL DERIVATIZATION OF PYRROLINE-CARBOXY-LYSINE AND PYRROLYSINE RESIDUES IRM LLC (BM) 2010-04-29 WO disclosed
US-20100092539-A1 Fluorinated GHRH Antagonists UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS 2010-04-15 US disclosed
WO-2009136352-A1 ANTI-ANGIOGENIC COMPOUNDS COVX TECHNOLOGIES IRELAND, LTD. (IE) 2009-11-12 WO disclosed
WO-2009120831-A2 NOVEL N-AND C-TERMINAL SUBSTITUTED ANTAGONISTIC ANALOGS OF GH-RH THE UNIVERSITY OF MIAMI (US) 2009-10-01 WO disclosed
EP-2100900-A1 Bombesin analog peptide antagonist conjugates Universitätsspital Basel (CH) 2009-09-16 EP disclosed
WO-2009109332-A1 BOMBESIN ANALOG PEPTIDE ANTAGONIST CONJUGATES UNIVERSITÄTSSPITAL BERN (CH) 2009-09-11 WO disclosed